Citation Impact

Citing Papers

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
2014
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
CRISPR/Cas9 in Genome Editing and Beyond
2016
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
2021 StandoutNobel
High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding
2017 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
International regulatory landscape and integration of corrective genome editing into in vitro fertilization
2014
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
2015 Standout
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
2016 StandoutNature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
CCR5 Gene Editing of Resting CD4+ T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice
2014
Expanding the Biologist’s Toolkit with CRISPR-Cas9
2015 StandoutNobel
Genome-Editing Technologies: Principles and Applications
2016
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
A Cure for HIV Infection: “Not in My Lifetime” or “Just Around the Corner”?
2016
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
2015
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
2019 StandoutNobel
In vitro and ex vivo strategies for intracellular delivery
2016 Nature
Enabling functional genomics with genome engineering
2015
Natural selection and infectious disease in human populations
2014
Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery
2015
A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
2016 StandoutNobel
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
2017 StandoutNatureNobel
Therapeutic genome editing: prospects and challenges
2015
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
Improved Cell-Penetrating Zinc-Finger Nuclease Proteins for Precision Genome Engineering
2015
Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications
2015
Engineering T Cells to Functionally Cure HIV-1 Infection
2015
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Search-and-replace genome editing without double-strand breaks or donor DNA
2019 StandoutNature
Development and Applications of CRISPR-Cas9 for Genome Engineering
2014 Standout
Conformational control of DNA target cleavage by CRISPR–Cas9
2015 StandoutNatureNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS
2006
Targeted genome editing in human repopulating haematopoietic stem cells
2014 Nature
A thermostable Cas9 with increased lifetime in human plasma
2017 StandoutNobel
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
2016 StandoutNobel
Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases
2016
Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9
2014
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Potential of Surgery for Curing Type 2 Diabetes Mellitus
2002
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
New Cell Sources for T Cell Engineering and Adoptive Immunotherapy
2015
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
2015
Genome-editing Technologies for Gene and Cell Therapy
2016
Genome-editing revolution: My whirlwind year with CRISPR
2015 StandoutNatureNobel
Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
2015
The Daunting Economics of Therapeutic Genome Editing
2019
Genome Editing B.C. (Before CRISPR): Lasting Lessons from the “Old Testament”
2018
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
A Cas9–guide RNA complex preorganized for target DNA recognition
2015 StandoutScienceNobel
Dynamics of CRISPR-Cas9 genome interrogation in living cells
2015 StandoutScienceNobel
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
2015
Adoptive cellular therapy: A race to the finish line
2015
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Systematic discovery of natural CRISPR-Cas12a inhibitors
2018 StandoutScienceNobel
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
2017 StandoutNobel
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
2016 StandoutScience
Genomic Engineering and the Future of Medicine
2015 StandoutNobel
TALEN Knockout of the PSIP1 Gene in Human Cells: Analyses of HIV-1 Replication and Allosteric Integrase Inhibitor Mechanism
2014
A New Class of Medicines through DNA Editing
2019
Rational design of a split-Cas9 enzyme complex
2015 StandoutNobel
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Don’t edit the human germ line
2015 Nature
Adopt a moratorium on heritable genome editing
2019 StandoutNatureNobel
Chimeric Antigen Receptor Therapy
2018 Standout
Delivery technologies for genome editing
2017
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
2015
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
2017
The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy
2012
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
2020 StandoutNobel
Genome Editing: A New Approach to Human Therapeutics
2015
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
CRISPR-Cas guides the future of genetic engineering
2018 StandoutScienceNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel

Works of David Stein being referenced

Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
2014
A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40
2005
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA
2016
Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.
1986
Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults
2017
Rankless by CCL
2026